Search results
Results From The WOW.Com Content Network
The National Institutes of Health Stroke Scale, or NIH Stroke Scale (NIHSS), is a tool used by healthcare providers to objectively quantify the impairment caused by a stroke and aid planning post-acute care disposition, though was intended to assess differences in interventions in clinical trials. The NIHSS was designed for the National ...
If any one of the three tests shows abnormal findings, the patient may be having a stroke and should be transported to a hospital as soon as possible. The CPSS was derived from the National Institutes of Health Stroke Scale developed in 1997 at the University of Cincinnati Medical Center for prehospital use. [2]
All NIH Institutes and Centers are involved with OSC in the design, implementation, and evaluation of Common Fund programs. [15] commonfund.nih.gov: Office of Technology Transfer: OTT manages the wide range of NIH and FDA intramural inventions as mandated by the Federal Technology Transfer Act and related legislation.
The Los Angeles Prehospital Stroke Screen (abbreviated LAPSS) is a method of identifying potential stroke patients in a pre-hospital setting. [ 1 ] Screening criteria
For example, a person aged 60 (1 point) with normal blood pressure (0 point) and without diabetes (0 point) who experienced a TIA lasting 10 minutes (1 point) with a speech disturbance but no weakness on one side of the body (1 point) would score a total of 3 points.
The scale was originally introduced in 1957 by Dr. John Rankin of Stobhill Hospital, Glasgow, Scotland as a 5-level scale ranging from 1 to 5. [ 3 ] [ 4 ] It was then modified by either van Swieten et al. [ 5 ] or perhaps Prof. C. Warlow's group at Western General Hospital in Edinburgh for use in the UK-TIA study in the late 1980s to include ...
As of 2011, NIH-supported research helped to discover 153 new FDA-approved drugs, vaccines, and new indications for drugs in the 40 years prior. [35] One study found NIH funding aided either directly or indirectly in developing the drugs or drug targets for all of the 210 FDA-approved drugs from 2010 to 2016. [36]
September 1993—The NIH Revitalization Act of 1993 (P.L. 103-43) directed NIAMS to establish "an information clearinghouse on osteoporosis and related bone disorders to facilitate and enhance knowledge and understanding on the part of health professionals, patients, and the public through the effective dissemination of information."